WCM
AST

WealthBridge Capital Management’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

WealthBridge Capital Management’s Portfolio AST Stock Details AST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-12
Closed – – 1118
2018
Q4 		$0 Buy
+12
New +$12 ﹤0.01% 998

WealthBridge Capital Management's AST Position: Q1 2019 in Review

WealthBridge Capital Management sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q1 2019, closing a stake of 12 shares.

WealthBridge Capital Management first reported a position in AST in Q4 2018 and held it in 1 quarter. The position peaked at $0 in Q4 2018. 0 funds tracked by Wall St. Rank hold AST as of Q1 2019.

  • WealthBridge Capital Management reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q1 2019 after selling out during the quarter.
  • WealthBridge Capital Management sold 12 Asterias Biotherapeutics Inc. Series A shares in Q1 2019.
  • WealthBridge Capital Management first reported a position in Asterias Biotherapeutics Inc. Series A in Q4 2018 and held it in 1 quarter.
  • WealthBridge Capital Management's Asterias Biotherapeutics Inc. Series A position peaked at $0 in Q4 2018.
  • 0 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q1 2019.

Based on WealthBridge Capital Management's 13F filing for Q1 2019, filed 15 May 2019.